COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 283: Articles 2821-2830  | Next

Modulation of Biophysical Properties of Nucleocapsid Protein in the Mutant Spectrum of SARS-CoV-2
Nguyen, A., Zhao, H., Myagmarsuren, D., Srinivasan, S., Wu, D., Chen, J., Piszczek, G., Schuck, P.
10.1101/2023.11.21.568093 — Posted: 2023-11-22
Seasonal Human Coronaviruses OC43, 229E, and NL63 Induce Cell Surface Modulation of Entry Receptors and Display Host Cell-Specific Viral Replication Kinetics
Siragam, V., Maltseva, M., Castonguay, N., Galipeau, Y., Srinivasan, M. M., Soto, J. H., Dankar, S., Langlois, M.-A.
10.1101/2023.11.20.567923 — Posted: 2023-11-22
Association Between COVID-19 During Pregnancy and Preterm Birth by Trimester of Infection: A Retrospective Cohort Study Using Longitudinal Social Media Data
Klein, A. Z., Kunatharaju, S., Golder, S., Levine, L. D., Figueiredo, J. C., Gonzalez-Hernandez, G.
10.1101/2023.11.17.23298696 — Posted: 2023-11-21
Affect and post-COVID-19 symptoms in daily life: An exploratory experience sampling study
Schaap, G., Wensink, M., Doggen, C. J. M., van der Palen, J., Vonkeman, H. E., Bode, C.
10.1101/2023.11.20.23298760 — Posted: 2023-11-21
Accurate Characterization of Conformational Ensembles and Binding Mechanisms of the SARS-CoV-2 Omicron BA.2 and BA.2.86 Spike Protein with the Host Receptor and Distinct Classes of Antibodies Using AlphaFold2-Augmented Integrative Computational Modeling
Raisinghani, N., Alshahrani, M., Gupta, G., Xiao, S., Tao, P., Verkhivker, G.
10.1101/2023.11.18.567697 — Posted: 2023-11-21
Human coronavirus OC43 infection remodels Connexin 43 mediated gap junction intercellular communication in vitro
Karmakar, S., Das Sarma, J.
10.1101/2023.11.20.567927 — Posted: 2023-11-21
Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung
Bishop, C. R., Rawle, D. J., Yan, K., Tang, B., Larcher, T., Suhrbier, A.
10.1101/2023.11.19.567745 — Posted: 2023-11-21
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86 lineages combining increased fitness and antibody evasion
Planas, D., Staropoli, I., Michel, V., Lemoine, F., Donati, F., Prot, M., Porrot, F., Benhassine, F. G., Jeyarajah, B., Brisebarre, A., Dehan, O., Bolland, W., Hubert, M., Buchreiser, J., Vanhoucke, T., Rosenbaum, P., Veyer, D., Pere, H., Lina, B., Assant, S. T., Hocqueloux, L., Prazuck, T., Loriere, E. S., Schwartz, O.
10.1101/2023.11.20.567873 — Posted: 2023-11-21
Comprehensive contact tracing during an outbreak of alpha-variant SARS-CoV-2 in a rural community reveals less viral genomic diversity and higher household secondary attack rates than expected
Sivertsen, A., Mortensen, N., Solem, U., Valen, E., Bullita, M. F., Wensaas, K.-A., Litleskare, S., Rortveit, G., Grewal, H. M. S., Ulvestad, E.
10.1101/2023.11.17.567570 — Posted: 2023-11-21
Deep Learning Approach to Measure Alveolar Bone Loss After COVID-19
Lee, S. W., Huz, K., Gorelick, K., Bina, T., Matsumura, S., Yin, N., Zhang, N., Naa Ardua Anang, Y., Li, J., Servin-DeMarrais, H. I., McMahon, D. J., Yin, M. T., Wadhwa, S., Lu, H.
10.1101/2023.11.20.23298788 — Posted: 2023-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).